• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 细胞激活因子耗竭可减轻非酒精性脂肪性肝病小鼠模型的肝脂肪堆积。

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease.

机构信息

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, 791-0295, Japan.

出版信息

Sci Rep. 2019 Jan 30;9(1):977. doi: 10.1038/s41598-018-37403-y.

DOI:10.1038/s41598-018-37403-y
PMID:30700810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6353938/
Abstract

Obesity-induced adipose-tissue dysfunction is a critical contributor to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). B cell-activating factor (BAFF) is an adipokine related to impaired insulin sensitivity, and the serum BAFF concentration is associated with NAFLD severity. In this study, we aimed to determine the direct in vivo role of BAFF in the development of insulin resistance, adipocyte dysfunction, and hepatic steatosis using BAFF mice fed a high-fat diet (HFD). HFD-fed BAFF mice exhibited significantly improved insulin sensitivity despite their increased weight gain and adiposity relative to HFD-fed wild-type mice. Moreover, inflammation, especially the accumulation of CD11c adipose-tissue macrophages, and fibrosis of epididymal adipose tissue were reduced, contributing to healthy adipose-tissue expansion in obese BAFF mice. In line with metabolically healthy obesity, hepatic steatosis also decreased, and we observed attenuated de novo lipogenesis in both the livers and hepatocytes of BAFF mice. Our data revealed that BAFF serves as a potential stimulator of unhealthy adipose-tissue expansion by triggering inflammation and fibrosis and ultimately leading to enhanced insulin resistance and NAFLD. Therefore, these results suggest that BAFF is a promising target for diabetes and NAFLD treatment.

摘要

肥胖引起的脂肪组织功能障碍是导致非酒精性脂肪性肝病(NAFLD)发病机制的关键因素。B 细胞激活因子(BAFF)是一种与胰岛素敏感性受损相关的脂肪因子,血清 BAFF 浓度与 NAFLD 严重程度相关。在这项研究中,我们旨在使用高脂肪饮食(HFD)喂养 BAFF 小鼠,确定 BAFF 在胰岛素抵抗、脂肪细胞功能障碍和肝脂肪变性发展中的直接体内作用。与 HFD 喂养的野生型小鼠相比,尽管 HFD 喂养的 BAFF 小鼠体重增加和肥胖程度增加,但它们的胰岛素敏感性显著改善。此外,炎症,特别是 CD11c 脂肪组织巨噬细胞的积累和附睾脂肪组织的纤维化减少,导致肥胖 BAFF 小鼠健康的脂肪组织扩张。符合代谢健康肥胖,肝脂肪变性也减少,我们观察到 BAFF 小鼠的肝脏和肝细胞中新生脂肪生成减弱。我们的数据表明,BAFF 通过触发炎症和纤维化,充当不健康脂肪组织扩张的潜在刺激物,最终导致增强的胰岛素抵抗和 NAFLD。因此,这些结果表明 BAFF 是治疗糖尿病和 NAFLD 的有希望的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/1540365469fb/41598_2018_37403_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/00a915ba3679/41598_2018_37403_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/f2572090ab56/41598_2018_37403_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/4f5865652a16/41598_2018_37403_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/3497510c0c9a/41598_2018_37403_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/506f0b1fa21e/41598_2018_37403_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/c02df1dc3d84/41598_2018_37403_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/1540365469fb/41598_2018_37403_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/00a915ba3679/41598_2018_37403_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/f2572090ab56/41598_2018_37403_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/4f5865652a16/41598_2018_37403_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/3497510c0c9a/41598_2018_37403_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/506f0b1fa21e/41598_2018_37403_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/c02df1dc3d84/41598_2018_37403_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/850b/6353938/1540365469fb/41598_2018_37403_Fig7_HTML.jpg

相似文献

1
Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease.B 细胞激活因子耗竭可减轻非酒精性脂肪性肝病小鼠模型的肝脂肪堆积。
Sci Rep. 2019 Jan 30;9(1):977. doi: 10.1038/s41598-018-37403-y.
2
Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.在高脂西方饮食诱导的肥胖相关非酒精性脂肪性肝病小鼠模型中的代谢表型以及脂肪和肝脏特征
Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15.
3
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.新型异喹啉生物碱(S)YS - 51通过抑制脂肪生成、炎症和凝血来减轻小鼠肥胖相关的非酒精性脂肪性肝病。
Eur J Pharmacol. 2016 Oct 5;788:200-209. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.
4
Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.吡格列酮可减轻磷脂酰乙醇胺N-甲基转移酶缺陷小鼠的肝脏炎症和纤维化。
Am J Physiol Gastrointest Liver Physiol. 2016 Apr 1;310(7):G526-38. doi: 10.1152/ajpgi.00243.2015. Epub 2016 Jan 21.
5
Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.四氢姜黄素对高脂饮食诱导肥胖小鼠肥胖和肝脂肪变性的抑制作用。
J Agric Food Chem. 2018 Dec 5;66(48):12685-12695. doi: 10.1021/acs.jafc.8b04624. Epub 2018 Nov 16.
6
Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. perilipin-2 通过不同的肝细胞和肝外细胞作用机制促进肥胖和进行性脂肪性肝病的发生。
J Physiol. 2019 Mar;597(6):1565-1584. doi: 10.1113/JP277140. Epub 2019 Jan 2.
7
Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.Vsig4 的表达可减轻高脂肪饮食(HFD)诱导的小鼠巨噬细胞介导的肝炎症和纤维化。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):858-865. doi: 10.1016/j.bbrc.2019.06.045. Epub 2019 Jun 29.
8
α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.α-山竹黄酮通过抑制C-C趋化因子受体2改善肝脂肪变性和胰岛素抵抗。
PLoS One. 2017 Jun 9;12(6):e0179204. doi: 10.1371/journal.pone.0179204. eCollection 2017.
9
Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.白细胞介素-1α 缺乏可减少饮食诱导肥胖小鼠的肥胖、葡萄糖不耐受和肝脏从头脂肪生成。
BMJ Open Diabetes Res Care. 2019 Oct 17;7(1):e000650. doi: 10.1136/bmjdrc-2019-000650. eCollection 2019.
10
Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.乌索苷 J 通过调节 AMPK/AKT 信号通路改善代谢紊乱和非酒精性脂肪性肝病。
Pharmacol Res. 2021 Jan;163:105298. doi: 10.1016/j.phrs.2020.105298. Epub 2020 Nov 18.

引用本文的文献

1
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC.代谢相关脂肪性肝病-代谢相关脂肪性肝炎-肝细胞癌(MASLD-MASH-HCC)发生发展中的微环境及MASH-HCC的相关治疗
Front Immunol. 2025 Apr 30;16:1569915. doi: 10.3389/fimmu.2025.1569915. eCollection 2025.
2
Thermotherapy has sexually dimorphic responses in APP/PS1 mice.热疗法在APP/PS1小鼠中有性别差异反应。
Aging (Albany NY). 2024 Nov 29;16(21):13237-13251. doi: 10.18632/aging.206156.
3
Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Oxidative Stress Inhibits Healthy Adipose Expansion Through Suppression of SREBF1-Mediated Lipogenic Pathway.氧化应激通过抑制 SREBF1 介导的脂肪生成途径抑制健康的脂肪扩张。
Diabetes. 2018 Jun;67(6):1113-1127. doi: 10.2337/db17-1032. Epub 2018 Apr 4.
2
Transforming growth factor beta superfamily regulation of adipose tissue biology in obesity.转化生长因子-β超家族对肥胖症中脂肪组织生物学的调节作用。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1160-1171. doi: 10.1016/j.bbadis.2018.01.025.
3
Repression of Adipose Tissue Fibrosis through a PRDM16-GTF2IRD1 Complex Improves Systemic Glucose Homeostasis.
免疫系统在代谢功能障碍相关脂肪性肝病中的积极作用。
Gastroenterol Rep (Oxf). 2024 Oct 15;12:goae089. doi: 10.1093/gastro/goae089. eCollection 2024.
4
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes.非酒精性脂肪性肝炎发病机制中的免疫系统失调:揭示 T 和 B 淋巴细胞的关键作用。
Front Immunol. 2024 Aug 1;15:1445634. doi: 10.3389/fimmu.2024.1445634. eCollection 2024.
5
Thermotherapy has Sexually Dimorphic Responses in APP/PS1 Mice.热疗在APP/PS1小鼠中有性别差异反应。
bioRxiv. 2024 Aug 8:2024.03.26.586836. doi: 10.1101/2024.03.26.586836.
6
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中双向免疫交叉对话。
Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009.
7
TNF superfamily control of tissue remodeling and fibrosis.肿瘤坏死因子超家族调控组织重塑和纤维化。
Front Immunol. 2023 Jul 3;14:1219907. doi: 10.3389/fimmu.2023.1219907. eCollection 2023.
8
Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample.在一个貌似健康的人群样本中,低度炎症与异质的脂蛋白亚类谱有关。
Lipids Health Dis. 2023 Jul 11;22(1):100. doi: 10.1186/s12944-023-01856-6.
9
Blocking BAFF Alleviates Hepatic Fibrosis in -Infected Mice.阻断B细胞活化因子可减轻感染小鼠的肝纤维化。
Pathogens. 2023 Jun 1;12(6):793. doi: 10.3390/pathogens12060793.
10
Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis.B 细胞激活因子在非酒精性脂肪性肝炎小鼠模型纤维化进展中的作用。
Int J Mol Sci. 2023 Jan 28;24(3):2509. doi: 10.3390/ijms24032509.
通过 PRDM16-GTF2IRD1 复合物抑制脂肪组织纤维化可改善全身葡萄糖稳态。
Cell Metab. 2018 Jan 9;27(1):180-194.e6. doi: 10.1016/j.cmet.2017.12.005.
4
Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.腺苷 A2A 受体破坏通过增加炎症反应和 SREBP1c 活性加剧非酒精性脂肪性肝病。
Hepatology. 2018 Jul;68(1):48-61. doi: 10.1002/hep.29777. Epub 2018 May 10.
5
Adipose Tissue Hypoxia, Inflammation, and Fibrosis in Obese Insulin-Sensitive and Obese Insulin-Resistant Subjects.肥胖胰岛素敏感和肥胖胰岛素抵抗受试者的脂肪组织缺氧、炎症和纤维化
J Clin Endocrinol Metab. 2016 Apr;101(4):1422-8. doi: 10.1210/jc.2015-4125. Epub 2016 Feb 12.
6
Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.靶向精氨酸酶-II通过抑制巨噬细胞炎症反应保护小鼠免受高脂饮食诱导的肝脂肪变性。
Sci Rep. 2016 Feb 5;6:20405. doi: 10.1038/srep20405.
7
B-cell-activating factor deficiency attenuates high-fat diet-induced glucose intolerance by potentiating adipose tissue function.B细胞激活因子缺乏通过增强脂肪组织功能减轻高脂饮食诱导的葡萄糖不耐受。
Biochem Biophys Res Commun. 2015 Sep 4;464(4):1171-1177. doi: 10.1016/j.bbrc.2015.07.099. Epub 2015 Jul 21.
8
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.B细胞活化因子与非酒精性脂肪性肝病的组织学严重程度相关。
Hepatol Int. 2013 Jun;7(2):539-47. doi: 10.1007/s12072-012-9345-8. Epub 2012 Feb 9.
9
BAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity.BAFF基因敲除通过调节高脂饮食诱导肥胖中的脂肪组织分布来改善全身炎症。
Exp Mol Med. 2015 Jan 16;47(1):e129. doi: 10.1038/emm.2014.98.
10
NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.2014年的非酒精性脂肪性肝病:非酒精性脂肪性肝病的遗传学、诊断及治疗进展
Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):65-6. doi: 10.1038/nrgastro.2014.232. Epub 2015 Jan 6.